Key result
Adenoviral delivery of human Arg UGA tRNA corrected prolonged action potential durations in cultured guinea pig cardiomyocytes expressing mutant hERG channels by restoring full-length hERG protein.
Why the study?
Loss-of-function hERG mutations causing premature termination codons account for approximately 30% of long-QT syndrome, a lethal cardiac disorder with limited treatment options.
Does adenoviral delivery of human Arg UGA tRNA correct action potential prolongation in cultured adult guinea pig cardiomyocytes expressing mutant hERG channels?
Does adenoviral delivery of human Arg UGA tRNA correct action potential prolongation in cultured adult guinea pig cardiomyocytes expressing mutant hERG channels?
Anticodon engineered tRNA can restore full-length hERG protein and correct action potential prolongation in preclinical models of long-QT syndrome caused by premature termination codons.
Disease-causing premature termination codons (PTCs) individually disrupt the functional expression of hundreds of genes and represent a pernicious clinical challenge. In the heart, loss-of-function mutations in the hERG potassium channel account for approximately 30% of long-QT syndrome arrhythmia, a lethal cardiac disorder with limited treatment options. Premature termination of ribosomal translation produces a truncated and, for potassium channels, a potentially dominant-negative protein that impairs the functional assembly of the wild-type homotetrameric hERG channel complex. We used high-throughput flow cytometry and patch-clamp electrophysiology to assess the trafficking and voltage-dependent activity of hERG channels carrying patient PTC variants that have been corrected by anticodon engineered tRNA. Adenoviral-mediated expression of mutant hERG channels in cultured adult guinea pig cardiomyocytes prolonged action potential durations, and this deleterious effect was corrected upon adenoviral delivery of a human Arg UGA tRNA to restore full-length hERG protein. The results demonstrate mutation-specific, context-agnostic PTC correction and elevate the therapeutic potential of this approach for rare genetic diseases caused by stop codons.
No takes yet. Share an insight, caveat, or question.
Blomquist et al. (2023) studied Long-QT syndrome. Anticodon engineered tRNA (human Arg UGA tRNA) was evaluated on Action potential duration and restoration of full-length hERG protein. Adenoviral delivery of human Arg UGA tRNA corrected prolonged action potential durations in cultured guinea pig cardiomyocytes expressing mutant hERG channels by restoring full-length hERG protein.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: